Rong He, Zhijie Weng, Yunkun Liu, Bingzhi Li, Wenxuan Wang, Wanrong Meng, Bo Li & Longjiang Li. (2023) Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors. Stem Cell Reviews and Reports 19:8, pages 2557-2575.
Crossref
Onofrio Laselva & Massimo Conese. 2022. Current Topics in iPSCs Technology. Current Topics in iPSCs Technology
303
332
.
Yang Yu. 2022. Current Progress in iPSC Disease Modeling. Current Progress in iPSC Disease Modeling
127
156
.
Zhiqiang Wang, Jing Zheng, Ruolang Pan & Ye Chen. (2021) Current status and future prospects of patient-derived induced pluripotent stem cells. Human Cell 34:6, pages 1601-1616.
Crossref
Pallavi Pushp, Diogo E. S. Nogueira, Carlos A. V. Rodrigues, Frederico C. Ferreira, Joaquim M. S. Cabral & Mukesh Kumar Gupta. (2020) A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem Cell Reviews and Reports 17:3, pages 748-776.
Crossref
Yu Lin, Xiang Ren, Yongjiang Chen & Danian Chen. (2021) Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment. Frontiers in Neuroscience 14.
Crossref
Julia Deinsberger & Benedikt Weber. 2021. iPSCs in Tissue Engineering. iPSCs in Tissue Engineering
77
97
.
Fernanda C.P. Mesquita, Camila Hochman-Mendez & Doris A. Taylor. 2021. Recent Advances in iPSC Technology. Recent Advances in iPSC Technology
209
229
.
Ellen Petzendorfer & Pascale V. Guillot. 2021. Cell Sources for iPSCs. Cell Sources for iPSCs
1
13
.
Pradeep Kumar Sundaravadivelu, Khyati Raina, Madhuri Thool, Arnab Ray, Jahnavy Madhukar Joshi, Vishwas Kaveeshwar, S. Sudhagar, Nibedita Lenka & Rajkumar P. Thummer. 2022. Cell Biology and Translational Medicine, Volume 15. Cell Biology and Translational Medicine, Volume 15
151
180
.
Julia Deinsberger, David Reisinger & Benedikt Weber. (2020) Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis. npj Regenerative Medicine 5:1.
Crossref
Joseph Davidson & Paolo De Coppi. 2020. Principles of Tissue Engineering. Principles of Tissue Engineering
457
466
.
Aline Yen Ling Wang & Charles Yuen Yung Loh. (2019) Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell Transplantation 28:1_suppl, pages 112S-131S.
Crossref
Joseph Davidson & Paolo De Coppi. 2019. Fetal Therapy. Fetal Therapy
532
539
.
Melanie Generali, Elisa A. Casanova, Debora Kehl, Debora Wanner, Simon P. Hoerstrup, Paolo Cinelli & Benedikt Weber. (2019) Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells. Acta Biomaterialia 97, pages 333-343.
Crossref
Bharath Kumar Velmurugan, Lohanathan Bharathi Priya, Paramasivan Poornima, Li‐Jen Lee & Rathinasamy Baskaran. (2018) Biomaterial aided differentiation and maturation of induced pluripotent stem cells. Journal of Cellular Physiology 234:6, pages 8443-8454.
Crossref
Krishna Kumar Haridhasapavalan, Manash P. Borgohain, Chandrima Dey, Bitan Saha, Gloria Narayan, Sachin Kumar & Rajkumar P. Thummer. (2019) An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Gene 686, pages 146-159.
Crossref
Daniela Di Tizio, Alessandra Di Serafino, Prabin Upadhyaya, Luca Sorino, Liborio Stuppia & Ivana Antonucci. (2018) The Impact of Epigenetic Signatures on Amniotic Fluid Stem Cell Fate. Stem Cells International 2018, pages 1-10.
Crossref
Sveva Bollini, Antonietta R. Silini, Asmita Banerjee, Susanne Wolbank, Carolina Balbi & Ornella Parolini. (2018) Cardiac Restoration Stemming From the Placenta Tree: Insights From Fetal and Perinatal Cell Biology. Frontiers in Physiology 9.
Crossref
Miryam Mebarki, Annelise Bennaceur & Laurence Bonhomme-Faivre. (2018) Human-cell-derived organoids as a new ex vivo model for drug assays in oncology. Drug Discovery Today 23:4, pages 857-863.
Crossref
Aline F. Ferreira, George A. Calin, Virgínia Picanço-Castro, Simone Kashima, Dimas T. Covas & Fabiola A. de Castro. (2018) Hematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulator. Journal of Cell Science 131:4.
Crossref
Nicholas Liang, Cleber A. Trujillo, Priscilla D. Negraes, Alysson R. Muotri, Claudiana Lameu & Henning Ulrich. (2018) Stem cell contributions to neurological disease modeling and personalized medicine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 54-62.
Crossref
Sindhu Subramaniam, Eleni Antoniadou, Paolo de Coppi & Anna L. David. 2018. Perinatal Stem Cells. Perinatal Stem Cells
3
20
.
S.W. Steven Shaw, Po-Jen Cheng, Yao-Lung Chang, An-Shine Chao, Tzu-Hao Wang, Shuenn-Dyh Chang, T'sang-T'ang Hsieh & Kuo-Hsuan Chang. (2017) Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS. Taiwanese Journal of Obstetrics and Gynecology 56:6, pages 770-774.
Crossref
Debora KehlMelanie GeneraliSabrina GörtzDiego GeeringJaroslav SlameckaSimon P. HoerstrupUlrich BleulBenedikt Weber. (2017) Amniotic Fluid Cells Show Higher Pluripotency-Related Gene Expression Than Allantoic Fluid Cells. Stem Cells and Development 26:19, pages 1424-1437.
Crossref
Yogita K. Adlakha & Pankaj Seth. (2017) The expanding horizon of MicroRNAs in cellular reprogramming. Progress in Neurobiology 148, pages 21-39.
Crossref
Qin Bian & Patrick Cahan. (2016) Computational Tools for Stem Cell Biology. Trends in Biotechnology 34:12, pages 993-1009.
Crossref
Christoph J. Niemietz, Vanessa Sauer, Jacqueline Stella, Lutz Fleischhauer, Gursimran Chandhok, Sarah Guttmann, Yesim Avsar, Shuling Guo, Elizabeth J. Ackermann, Jared Gollob, Brett P. Monia, Andree Zibert & Hartmut H. -J. Schmidt. (2016) Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells. PLOS ONE 11:9, pages e0161455.
Crossref